Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 84Lymphoma, Non-Hodgkin 71Lymphoma 62Lymphoma, Follicular 58Lymphoma, Mantle-Cell 57Lymphoma, Large B-Cell, Diffuse 40Multiple Myeloma 36Hodgkin Disease 30Lymphoma, B-Cell, Marginal Zone 28Recurrence 27Lymphoma, B-Cell 19Leukemia 18Waldenstrom Macroglobulinemia 14Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasms, Plasma Cell 8Lymphoma, T-Cell 7Leukemia, Myeloid, Acute 7Burkitt Lymphoma 7Lymphoma, T-Cell, Peripheral 6Leukemia, B-Cell 6Hematologic Neoplasms 6Sezary Syndrome 5Myelodysplastic Syndromes 5Mycosis Fungoides 5Immune System Diseases 5Small Cell Lung Carcinoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

Standard of Care 4Practice Guidelines as Topic 4Methods 4Interviews as Topic 4Educational Status 4Early Intervention, Educational 4Specimen Handling 2Exercise Test 2Counseling 2Behavior Therapy 2fludarabine 1Whole-Body Irradiation 1Watchful Waiting 1Telemedicine 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Psychotherapy 1Positron-Emission Tomography 1Palliative Care 1Observation 1Mycophenolic Acid 1Music Therapy 1Mindfulness-Based Stress Reduction 1Mindfulness 1Melphalan 1Liquid Biopsy 1Health Promotion 1Granulocyte Colony-Stimulating Factor 1Geriatric Assessment 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hematopoietic and Lymphoid System Neoplasm × Bendamustine Hydrochloride × Clear all
NCT04022239 2026-01-12

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
25 enrolled

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡